Original Query: ALL
Previous Study | Return to List | Next Study
BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
|ClinicalTrials.gov Identifier: NCT00287495|
Recruitment Status : Terminated
First Posted : February 6, 2006
Last Update Posted : March 22, 2018
National Cancer Institute (NCI)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Terminated|
|Primary Completion Date :||September 21, 2012|
|Study Completion Date :||October 18, 2017|
Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996 Aug;2(8):925-8.
Biggar RJ, Rosenberg PS, Coté T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group. Int J Cancer. 1996 Dec 11;68(6):754-8. Erratum in: Int J Cancer 1997 Mar 17;70(6):727.